MindWalk Holdings Corp. (HYFT) vs Inovio Pharmaceuticals, Inc. (INO)
A side-by-side comparison of MindWalk Holdings Corp. and Inovio Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HYFT
MindWalk Holdings Corp.
$1.52HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
INO
Inovio Pharmaceuticals, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — HYFT vs INO
growth of $100 · dividends reinvested · last 10yHYFT -66.0% (-10.2%/yr)INO -98.6% (-34.9%/yr)HYFT compounded faster over this window
Log scale — wide-divergence pair
HYFT INO
HYFT vs INO: by the numbers
- •INO is the larger company ($78M vs $71M market cap).
- •Both run net losses; HYFT's is the smaller (-105.29% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | HYFT | INO |
|---|---|---|
| P/S ratio | 6.07 | N/A |
| P/B ratio | 14.44 | 17.86 |
Profitability
| Metric | HYFT | INO |
|---|---|---|
| Gross margin | 60.78% | 100.00% |
| Operating margin | -96.01% | -132871.32% |
| Net margin | -105.29% | -130000.00% |
| ROE | -250.39% | -1542.57% |
| ROIC | -153.46% | -836.58% |
Growth (annualized)
| Metric | HYFT | INO |
|---|---|---|
| Revenue CAGR (5Y) | -4.48% | N/A |
| Total return CAGR (5Y) | -23.93% | -57.05% |
Frequently asked
- How have HYFT and INO total returns compared?
- Over the past 5 years, HYFT delivered -23.93% and INO delivered -57.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.